You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
艾迪藥業(688488.SH)擬向參股公司香港優瑞增資
格隆匯 01-07 18:21

格隆匯1月7日丨艾迪藥業(688488.SH)公佈,公司擬對參股公司優瑞(香港)有限公司(以下簡稱“香港優瑞”或“標的公司”)以貨幣形式增加出資。香港優瑞本次增資額度總計金額為350萬美元,摺合人民幣約為2261.28萬元,公司擬對香港優瑞的投資額區間為226.66萬美元至350萬美元,公司在香港優瑞增資後的最終股權比例區間為38.3304%至48.1975%,增資第一階段相較於未經審計的賬面淨資產的溢價率為836.31%,增資第二階段相較於未經審計的賬面淨資產的溢價率為975.70%。其他股東對香港優瑞第二階段的增資安排尚在商談階段。本次增資完成後,公司對香港優瑞不構成控制,會計處理維持權益法核算。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account